搜索临床试验以:舒尼替尼 (SU011248)
总计495个结果
-
The Methodist Hospital Research InstituteSchering-Plough终止
-
PfizerInternational Metastatic Renal Cell Carcinoma Database Consortium (IMDC); Analysis Group完全的
-
Gustave Roussy, Cancer Campus, Grand ParisNational Cancer Institute, France; European Network for the Study of Adrenal Tumours完全的
-
Peking University Cancer Hospital & Institute未知
-
Massachusetts General HospitalUnited States Department of Defense完全的
-
Fondazione IRCCS Istituto Nazionale dei Tumori,...招聘中
-
Assistance Publique - Hôpitaux de Paris终止
-
National University Hospital, Singapore未知
-
Dana-Farber Cancer InstituteMassachusetts General Hospital; Beth Israel Deaconess Medical Center; Brigham and Women's Hospital完全的
-
Spanish Oncology Genito-Urinary Group完全的
-
University of UtahNational Comprehensive Cancer Network完全的
-
Association of Urologic Oncology (AUO)University Hospital, Essen未知
-
Novartis Pharmaceuticals完全的癌,肾细胞美国, 加拿大, 西班牙, 英国, 台湾, 荷兰, 澳大利亚, 德国, 意大利, 日本, 瑞典, 中国, 爱尔兰, 大韩民国
-
Instituto do Cancer do Estado de São PauloPfizer未知
-
Jiangsu HengRui Medicine Co., Ltd.Cancer Institute and Hospital, Chinese Academy of Medical Sciences完全的
-
Asan Medical CenterSamsung Medical Center; Seoul National University Hospital; Kyungpook National University Hospital未知
-
University of California, San FranciscoNational Cancer Institute (NCI)终止
-
Abramson Cancer Center of the University of PennsylvaniaNational Cancer Institute (NCI)未知
-
Deciphera Pharmaceuticals LLC招聘中要旨美国, 大韩民国, 西班牙, 法国, 台湾, 意大利, 澳大利亚, 加拿大, 德国, 英国, 荷兰, 巴西, 智利, 波兰